Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Revenue: 2017-2025

Historic Revenue for Assembly Biosciences (ASMB) over the last 6 years, with Sep 2025 value amounting to $10.8 million.

  • Assembly Biosciences' Revenue rose 57.62% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.2 million, marking a year-over-year increase of 31.30%. This contributed to the annual value of $28.5 million for FY2024, which is 298.16% up from last year.
  • According to the latest figures from Q3 2025, Assembly Biosciences' Revenue is $10.8 million, which was up 12.08% from $9.6 million recorded in Q2 2025.
  • Assembly Biosciences' 5-year Revenue high stood at $10.8 million for Q3 2025, and its period low was $5.8 million during Q1 2024.
  • Moreover, its 3-year median value for Revenue was $7.9 million (2024), whereas its average is $8.2 million.
  • Its Revenue has fluctuated over the past 5 years, first tumbled by 81.93% in 2021, then surged by 62.82% in 2025.
  • Over the past 4 years, Assembly Biosciences' Revenue (Quarterly) stood at $6.3 million in 2021, then reached $7.2 million in 2023, then increased by 2.71% to $7.4 million in 2024, then soared by 57.62% to $10.8 million in 2025.
  • Its Revenue stands at $10.8 million for Q3 2025, versus $9.6 million for Q2 2025 and $9.4 million for Q1 2025.